# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-278804
Filing Date
2025-11-13
Accepted
2025-11-13 07:00:39
Documents
42
Period of Report
2025-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aldx-20251113.htm iXBRL | 8-K | 72402
2 | EX-99.1 | aldx-ex99_1.htm | EX-99.1 | 33230
3 | EX-99.2 | aldx-ex99_2.htm | EX-99.2 | 22541
4 | GRAPHIC | aldx-ex99_1s1.jpg | GRAPHIC | 242002
5 | GRAPHIC | aldx-ex99_1s2.jpg | GRAPHIC | 975494
6 | GRAPHIC | aldx-ex99_1s3.jpg | GRAPHIC | 455924
7 | GRAPHIC | aldx-ex99_1s4.jpg | GRAPHIC | 192235
8 | GRAPHIC | aldx-ex99_1s5.jpg | GRAPHIC | 386791
9 | GRAPHIC | aldx-ex99_1s6.jpg | GRAPHIC | 309690
10 | GRAPHIC | aldx-ex99_1s7.jpg | GRAPHIC | 236490
11 | GRAPHIC | aldx-ex99_1s8.jpg | GRAPHIC | 417870
12 | GRAPHIC | aldx-ex99_1s9.jpg | GRAPHIC | 320276
13 | GRAPHIC | aldx-ex99_1s10.jpg | GRAPHIC | 361430
14 | GRAPHIC | aldx-ex99_1s11.jpg | GRAPHIC | 291637
15 | GRAPHIC | aldx-ex99_1s12.jpg | GRAPHIC | 194682
16 | GRAPHIC | aldx-ex99_1s13.jpg | GRAPHIC | 355289
17 | GRAPHIC | aldx-ex99_1s14.jpg | GRAPHIC | 335209
18 | GRAPHIC | aldx-ex99_1s15.jpg | GRAPHIC | 425540
19 | GRAPHIC | aldx-ex99_1s16.jpg | GRAPHIC | 364373
20 | GRAPHIC | aldx-ex99_1s17.jpg | GRAPHIC | 272167
21 | GRAPHIC | aldx-ex99_1s18.jpg | GRAPHIC | 329109
22 | GRAPHIC | aldx-ex99_1s19.jpg | GRAPHIC | 313390
23 | GRAPHIC | aldx-ex99_1s20.jpg | GRAPHIC | 316515
24 | GRAPHIC | aldx-ex99_1s21.jpg | GRAPHIC | 357823
25 | GRAPHIC | aldx-ex99_1s22.jpg | GRAPHIC | 454641
26 | GRAPHIC | aldx-ex99_1s23.jpg | GRAPHIC | 408898
27 | GRAPHIC | aldx-ex99_1s24.jpg | GRAPHIC | 192687
28 | GRAPHIC | aldx-ex99_1s25.jpg | GRAPHIC | 393029
29 | GRAPHIC | aldx-ex99_1s26.jpg | GRAPHIC | 363892
30 | GRAPHIC | aldx-ex99_1s27.jpg | GRAPHIC | 475088
31 | GRAPHIC | aldx-ex99_1s28.jpg | GRAPHIC | 449327
32 | GRAPHIC | aldx-ex99_1s29.jpg | GRAPHIC | 136684
33 | GRAPHIC | aldx-ex99_1s30.jpg | GRAPHIC | 321738
| Complete submission text file | 0001193125-25-278804.txt |  | 14927578

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
34 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | aldx-20251113.xsd | EX-101.SCH | 30863
44 | EXTRACTED XBRL INSTANCE DOCUMENT | aldx-20251113_htm.xml | XML | 4712

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 251475328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)